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Neospora caninum is the etiologic agent of neosporosis, is one of the main responsible 
for abortion in cattle herds, causing economic losses to Cattle-raising. Vaccination of 
cattle would be an important alternative; however, the lack of effective vaccines prevents 
the application of this control method. The proteins present in rhoptries (ROPs), due to 
their importance in cell infection and their antigenic and immunogenic characteristics, 
became excellent candidates for vaccine antigens. The bacterial lipoproteins as an Oprl 
from Pseudomonas aeruginosa have received particular attention as an adjuvant carrier 
molecule. The aims of this study were to clone and expressing a chimera containing 
NcROP2 fused with OprI lipoprotein from P. aeruginosa for the future development of a 
recombinant vaccine against N. caninum. We cloned and expressed, in Escherichia coli 
Rosetta (DE3) pLysS, the region of NcROP2 described between amino acids 191 and 
359, fused OprI producing the chimera rROP2/OprI, showed an expected size of ~50 kDa. 
and characterized its antigenicity. The protein was purified and characterized by Western 
blot with anti-histidine monoclonal antibodies and their antigenicity recognized by sera 
from animals naturally infected by N. caninum. The chimera rROP2/OprI was recognized 
by antibodies anti-N. caninum reviling common antigenic determinants of the 
recombinant protein and its native form, suggesting its use for developing a recombinant 
vaccine. 
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RESUMO 
Neospora caninum é o agente etiológico da neosporose, uma das principais doenças 
responsáveis por abortos em rebanhos bovinos, causando assim perdas econômicas a 
pecuária. A vacinação dos bovinos poderia ser uma alternativa interessante, porém a falta 
de vacinas eficazes impede a aplicação desse método de controle. As proteínas presentes 
nas róptrias (ROPs), devido sua importância na infecção de células e características 
imunogênicas e antigênicas, tornam-se excelentes candidatas como antígenos vacinais. 
Lipoproteínas bacterianas como a OprI de Pseudomonas aeruginosa tem recebido 
particular atenção como moléculas adjuvantes carreadoras. Os objetivos deste estudo 
foram clonar e expressar a quimera contendo NcROP2 fusionada a lipoproteína OprI de 
P. aeruginosa para o futuro desenvolvimento de uma vacina recombinante contra N. 
caninum.  Nós clonamos e expressamos, em Escherichia coli Rosetta (DE3) pLysS, a 
região de NcROP2 entre os aminoácidos 191 e 359, fusionado a OprI na quimera 
rROP2/OprI, demonstrando o tamanho predito de ~50 kDa e caracterizando sua 
antigenicidade. A proteína foi purificada e caracterizada por Western blot com anticorpos 
monoclonais anti-histidina e sua antigenicidade reconhecida por soros de animais 
naturalmente infectados por N. caninum. A quimera rROP2/OprI foi reconhecida por 
anticorpos anti-N. caninum, revelando determinantes antigênicos comuns entre a proteína 
recombinante e a forma nativa de NcROP2, o que sugere a possibilidade de seu uso no 
desenvolvimento de uma vacina recombinante.  
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The parasite Neospora caninum is the main cause of abortion in cattle in many 
countries around the world and causes important economic losses to the cattle industry 
(Dubey, 2003; Cerqueira-César et al., 2017; Majewski et al., 2020). In the last years 
several subunit vaccines based on proteins involved in adhesion, invasion, and 
intracellular proliferation of N. caninum, and immunodominant antigens have been 
evaluated as targets for vaccine development (Debache et al., 2009; Monney et al., 2011, 
Pastor-Fernández et al., 2015). Rhoptry proteins, such as NcROP2, are involved in a 
variety of cellular functions related to parasite-host cell interaction (Alaeddine et al., 
2013; Dubremetz, 2007; Saeij et al., 2007), and has been regarded as a promising antigen 
candidate for use in vaccines. 
The lipoprotein, OprI is the most abundant component from outer membrane of 
Pseudomonas aeruginosa, and there is a large body of evidence that the innate immune 
system recognizes it by Toll-like receptor -2 (TLR-2) (Kawa and Akira, 2009). The use 
of OprI as an adjuvant fusion protein has been reported (Myzuno and Kageyama 1978; 
Cornelis et al., 1996; Basto et al., 2012; 2015). Cote-Sierra et al., (2002), reported the use 
of OprI fused with a protein from Leishmania major was able to induce immune response 
towards a protective T helper (Th)1 profile. More recently, it was shown that OprI was 
fused to the chimeric N. caninum antigen Mic3-1-R was able to induce an immune 
response with mixed Th1 and Th2 properties in mice (Aguado-Martínez et al., 2016).  
The aims of this study were to clone and expressing a chimera containing NcROP2 
fused with OprI lipoprotein from P. aeruginosa for the future development of a 
recombinant vaccine against N. caninum. 
 
2 MATERIALS AND METHODS 
2.1 NEOSPORA CANINUM STRAIN AND DNA EXTRACTION 
Neospora caninum isolate NC-1 used in this study was provided by the laboratory 
of parasitic diseases, Federal University of Santa Maria. The parasite was propagated in 
Vero cells using Dulbecco’s modified essential medium supplemented with 10% fetal 
calf serum, at 37 ºC in a humidified atmosphere of 5% CO2. When 80% of the Vero cells 
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had been destroyed by the tachyzoites, the monolayer cells were removed and washed 
twice with phosphate buffered saline (PBS) solution and centrifuged at 1000×g for 10 
minutes. The genomic DNA from tachyzoites was isolated according to the method 
described by Sambrook and Russell (2001). 
 
2.2 PRIMERS, PCR, CLONING, AND DNA SEQUENCING 
Oligonucleotide primers to the ROP2 from Neospora caninum (NcROP2) used in 
this study, were described previously by Monney et al. (2011), however, for correct 
reading frame fusion with the Pseudomonas aeruginosa OprI subunit, cleavage sites for 
EcoRI and XhOI were added in forward (3’-ACGAATTCCTGCGACCAGGCCA-5’) 
and reverse (3’-CTCATCCGGCGTGTTAGTCGGG-5’) primers. PCR was performed 
with a final volume of 25 µl containing a solution containing approximately 40 ng of the 
extracted DNA, 100 mM of dNTP, 2 units of Taq DNA polymerase, 10× reaction buffer, 
50 mM MgCl2, 0.01 pmol of each primer. The PCR amplification consisted in 30 cycles 
of 94 ºC for 1min, 58 ºC for 1min, and 72 ºC also for 1 min. 
After DNA amplification, the PCR product obtained was purified with 
NucleoSpin® Gel and PCR Clean-up kit (Macherey-Nagel). PCR products and pOLT7 
expression vector, which containing OprI gene (Basto et al., 2012), were digested with 
restriction enzymes EcoRI and XhOI (New England Biolabs), and ligated with T4 DNA 
ligase (New England Biolabs). The resulted product (pOLT7/rROP2/OprI) was used to 
transform Escherichia coli strain TOP10F by heat shock method and transformants were 
selected in Luria Bertani (LB) plates (1% tryptone, 0.5% yeast extract, 0.5% NaCl, and 
2% agar) supplemented with kanamycin (30 µg/ml). Bacterial clones were screened for 
recombinants and plasmid DNA was extracted using NucleoSpin® Plasmid kit 
(Macherey-Nagel). Recombinant clones were characterized by endonuclease digestion 
and confirmed by colony PCR with the above primers. Also, one of these recombinant 
clones was propagated and plasmid DNA was sequenced to confirm that the sequence of 
the insert was as expected. The sequencing was performed in ABI prism® 3500 Genetic 
Analyzer (Applied Biosystems). 
 
2.3 EXPRESSION OF RECOMBINANT CHIMERA RROP2/OPRI 
The recombinant vector pOLT7/rROP2/OprI was transformed into E. coli Rosetta 
BL21 DE3 pLysS (Novagen) by heat shock method. Transformed cells were grown in 
LB broth supplemented with 30 μg/mL of kanamycin and 34 μg/mL of chloramphenicol 
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in an orbital shaker maintained at 200 rpm, overnight at 37 °C. The Cultures were diluted 
at 1:20 (v/v) in fresh medium, and the incubation proceeded at the same conditions until 
the mid-log growth phase (OD600 = 0.8−1.0). Recombinant protein expression was 
induced for 3 h by the addition of isopropyl β-D-1 thiogalactopyranoside (IPTG) to a final 
concentration of 1 mM. The cells were harvested by centrifugation at 5,500×g for 20 min 
at 4 °C. 
 
2.4 PREPARATION OF OUTER MEMBRANES, DEPYROGENATION AND 
LIPOPOLYSACCHARIDE EXTRACTION 
The bacterial outer membranes were prepared by differential solubilization with 
N-lauroylsarcosine sodium salt solution (sarkosyl) and outer membrane depyrogenation 
was performed by hot phenol/water extraction as previously described (Basto et al., 2014) 
with minor modifications. Briefly, the pellet cells were washed with PBS, and 
resuspended in 25 mL of lysis buffer (25 mM Tris–HCl pH 8.0, 50 mM glucose, 10 mM 
EDTA), with 2.5 mg/mL of lysozyme and 1 mM phenylmethylsulfonyl fluoride (PMSF). 
After 30 min of incubation on ice, equal volume of 2% (w/v) sarkosyl was added, the 
mixture was homogenized and then ultra-sonicated. Finally, the cell lysate was ultra-
centrifuged at 40,000 × g for 4 h at 4 ºC to obtain an insoluble outer membrane pellet. 
The outer membrane pellets were resuspended in 10 mL of PBS after an equal volume of 
65 ºC heated phenol (Sigma) was added, then the samples were heated at 65 ºC for 15 
min and vortexed intermittently for 15 min, followed by centrifugation at 13,400 × g for 
15 min at 4 ºC. The upper lipopolysaccharide (LPS) containing aqueous phase was 
removed and the phenol phase was treated, twice, with 65 ºC heated deionized water, in 
the same conditions, followed by centrifugation. The phenol phase was transferred to new 
tubes, 5-volumes of pre-chilled 0.1 M ammonium acetate in methanol were added and 
proteins were allowed to precipitate overnight at -20 ºC. The protein precipitates were 
centrifuged as above and the pellets were sequentially washed in pre-chilled 0.1 M 
ammonium acetate in methanol, 100% ethanol and acetone, and finally air-dried at room 
temperature. 
 
2.5 PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHY 
The recombinant protein purification was performed by affinity chromatography 
with Ni2+ under denaturing conditions as previously described by Basto et al. (2012), but 
with minor modifications. Briefly, the protein precipitates were resuspended in 10 mL of 
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binding buffer (20 mM NaH2PO4, 0.5 M NaCl, 20 mM imidazole, 6 M guanidine 
hydrochloride, 2% (v/v) Triton X-100, 20 mM β-mercaptoethanol, and protease inhibitor 
cocktail (Complete, Mini, EDTA-free, Roche), pH 7.4), and incubated with soft agitation, 
overnight, at room temperature. The followed day, samples were centrifuged at 20,000×g 
for 15 min at 4 ºC, after the pH were adjusting to 7.4, and the supernatants were incubated 
with Ni Sepharose 6 Fast Flow (GE Healthcare) at the ratio 1 mL protein sample/100 µL 
resin, during 2 h at room temperature. After the samples were transferred to an empty 
PD10 column (GE Healthcare), the chromatographic columns were washed with 20 resin-
bed volumes of buffer W1-TX100 (20 mM NaH2PO4, 0.5 M NaCl, 20 mM imidazole, 8 
M urea, 2% (v/v) Triton X-100, pH 7.4). The detergents were removed from the columns 
with 20 resin-bed volumes of buffer W2 (20 mM NaH2PO4, 0.5 M NaCl, 8 M urea, pH 
7.4) and the elution was performed with elution buffer (20 mM NaH2PO4,0.5 NaCl M, 8 
M urea, pH 4.5) in acidic conditions. The eluates were dialyzed against PBS, aliquoted in 
Protein LoBind tubes (Eppendorf), and stored at −80 ºC. The concentration of 
recombinant protein was measured by the BCATM Protein Assay kit (Pierce) according to 
the manufacturer’s instructions. 
 
2.6 SDS-PAGE AND WESTERN BLOTTING 
Purified proteins were boiled in SDS-PAGE loading buffer and separated on 15% 
separating gel in Mini-PROTEAN electrophoresis system (Bio-Rad). The gel was stained 
with Coomassie Brilliant Blue R250. For Western blotting, proteins were transferred onto 
a nitrocellulose membrane using Bio-Rad Mini Trans-Blot Cell. The membrane was 
blocked with 5% non-fat dry milk and antigenic proteins were detected by incubating 
membrane with the MAb Anti-6xHis HRP conjugated (1:5,000) or sera (1:100) from 
naturally infected animals (cattle and sheep) with N. caninum. Membranes were then 
incubated anti-bovine or anti-sheep (1:10,000) immunoglobulins HRP conjugated. The 
recombinant protein was detected when the membrane is placed in DAB solution (0.6 mg 
diaminobenzidine, 0.03% nickel sulfate, 50mM Tris–HCl pH 8.0, and hydrogen peroxide 
30 vol.) until a colored reaction appeared.  
 
3 RESULTS  
3.1 PCR, AMPLIFICATION OF ROP2 FRAGMENT, AND CLONING 
The expected 522 bp of the parasite DNA gene fragment that encodes for NcROP2 
protein (aminoacid 191 to 359) was amplified by PCR (Fig. 1). Amplified fragments were 
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purified and cloned into the pOLT7 expression vector, which containing OprI gene, 
resulting expression construct, pOLT7/rROP2/OprI. The E. coli TOP10F transformed 
with this expression construct resulted in several kanamycin-resistant colonies, which 
were screening and confirmed by colony PCR (Fig. 1). One of these clones was 
propagated in liquid culture and plasmid DNA was extracted and sequenced. A BLAST 
(Basic Local Alignment and Search Tool) was performed showing a perfect alignment 
(100% identity) with the original sequence of NcROP2 deposited on GenBank (Accession 
No. HM587954). 
 
Figure 1. Electrophoresis in 1% agarose gel. Amplification of the NcROP2 gene through the PCR 
technique. 1. DNA Ladder (pb); 2. Amplified NcRop2 gene; 3. Vector pOLT7 cloned with the NcROP2 
gene; 4. Topo vector cloned with the NcROP2 gene. 
 
 
3.2 EXPRESSION AND PURIFICATION OF THE RECOMBINANT PROTEIN 
The E. coli Rosetta BL21 DE3 pLysS transformed with the expression plasmid 
pOLT7/rROP2/OprI, in the presence of IPTG, expressed a recombinant protein of 
approximately 50 kDa. Also, through the protocol of preparation of the outer membrane 
and extraction of the LPS used in this study, it was possible to purify the recombinant 
chimera rROP2/OprI through affinity chromatography, using Ni+ resin (Fig. 2A). The 
protein yield obtained with this process was approximately 534mg/L.  
 
3.3 CHARACTERIZATION OF THE CHIMERA RROP2/OPRI BY WESTERN 
BLOTTING 
The characterization of the rROP2/OprI chimera was performed using the Western 
Blot analysis. The reaction using MAb Anti-6xHis (Fig. 2B), showing a band of 
approximately 50 kDa, this indicating the presence of histidine tail in the N-terminal 
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portion of the chimera constituted by the fusion of NcROP2 with OprI. The rROP2/OprI 
was recognized by sera from cattle and sheep naturally infected with N. caninum, showing 
his antigenicity (Fig. 2B). 
 
Figure 2. Protein expression and characterization. A) SDS-PAGE (15%) staining with Coomassie Blue. 1. 
Protein Ladder; 2. Transformed E. coli Rosetta (DE3) pLysS50 before induction with IPTG; 3. Transformed 
E. coli Rosetta (DE3) pLysS50 after the induction with IPTG; 4. Samples after the preparation of outer 
membranes; 5. Purified rRop2/Oprl; B) Western blotting analysis of recombinant purified chimera 
rROP2/OprI. 1. Protein Ladder; 2. Anti-6xHis monoclonal antibody; 3. Sera from cattle naturally infected 




Neospora caninum is the main parasite cause of abortion in cattle around the 
world, leading to an important animal health problem with high economic losses. So, a 
vaccine is a rational approach for the control of the disease (Hemphill et al., 2016; 
Pinheiro et al., 2018). Rhoptry proteins, such as NcROP2, are involved in a variety of 
cellular functions related to parasite–host cell interaction, such as cell invasion and 
formation of the parasitophorous vacuole (Alaeddine et al., 2013; Dubremetz, 2007; Saeij 
et al., 2007). Different studies reported that NcROP2 antigen are a promisor candidate to 
a subunit recombinant vaccine (Debache et al., 2008; 2009; Monney et al., 2011; Pastor-
Fernández et al., 2015).  In addition, it was shown that OprI fused to the chimeric N. 
caninum antigen Mic3-1-R was able to induce an immune response with mixed Th1 and 
Th2 properties (Aguado-Martínez et al., 2016). 
 In this study, we demonstrated the successful expression of the recombinant 
chimera composed by the fusion of a NcROP2 from N. caninum with a lipoprotein OprI 
from P. aeruginosa. The histidine tail in the N-terminal portion of the recombinant protein 
present in the expression vector (Basto et al., 2012), make possible to detect the chimeric 
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protein expression by Western blotting using MAb Anti-6xHis. Noteworthy, was the 
antigenic characterization of chimera rROP2/OprI, confirmed by immunoblotting using 
sera from cattle and sheep naturally infected with N. caninum, showing that the 
rROP2/OprI retained native NcROP2 characteristics. The present study has some 
limitations, first we did not evaluate the immunogenicity of the chimera, as well as we 
did not perform any vaccination-challenge study. But the chimeric obtained of OprI fused 
with NcROP2 achieved in this study, can be a promising alternative for the formulation 
of the recombinant vaccine against N. caninum. 
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